<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<colgroup>
<col width="16.24%"></col>
<col width="83.76%"></col>
</colgroup>
<tbody>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="middle">
<content stylecode="bold">Bleeding </content>
<content stylecode="bold">times</content>
<content stylecode="bold"></content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="middle">
<content stylecode="italics">Clinical </content>
<content stylecode="italics">Impact:</content>
<br/>
</td>
<td stylecode="Rrule" valign="middle">Naproxen may decrease platelet aggregation and prolong bleeding time.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="middle">
<content stylecode="italics">Intervention:</content>
<br/>
</td>
<td stylecode="Rrule" valign="middle">This effect should be kept in mind when bleeding times are determined.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="middle">
<content stylecode="bold">Porter-Silber </content>
<content stylecode="bold">test</content>
<content stylecode="bold"></content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Clinical </content>
<content stylecode="italics">Impact:</content>
<br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">The administration of naproxen may result in increased urinary values for 17-ketogenic steroids because of an interaction between the drug and/or its metabolites with m-di-nitrobenzene used in this assay.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Intervention:</content>
<br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">Although 17-hydroxy-corticosteroid measurements (Porter-Silber test) do not appear to be artifactually altered, it is suggested that therapy with naproxen be temporarily discontinued 72 hours before adrenal function tests are performed if the Porter-Silber test is to be used.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="middle">
<content stylecode="bold">Urinary </content>
<content stylecode="bold">assays of 5-hydroxy indoleacetic acid (5HIAA)</content>
<content stylecode="bold"></content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Clinical </content>
<content stylecode="italics">Impact:</content>
<br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">Naproxen  may interfere with some urinary assays of 5-hydroxy  indoleacetic acid (5HIAA).<br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Intervention:</content>
<br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">This  effect should be  kept in mind when  urinary  5-hydroxy  indoleacetic acid is determined.<br/>
</td>
</tr>
</tbody>
</table>